• University of Edinburgh Featured Masters Courses
  • Northumbria University Featured Masters Courses
  • University of Leeds Featured Masters Courses
  • University of Bristol Featured Masters Courses
  • Aberystwyth University Featured Masters Courses
  • Jacobs University Bremen gGmbH Featured Masters Courses
  • University of Derby Online Learning Featured Masters Courses

Postgrad LIVE! Study Fair

Birmingham | Bristol | Sheffield | Liverpool | Edinburgh

University of Nottingham in China Featured Masters Courses
Nottingham Trent University Featured Masters Courses
University of Cambridge Featured Masters Courses
University of Reading Featured Masters Courses
ETH Zürich Featured Masters Courses
"cancer" AND "treatment"×
0 miles

Masters Degrees (Cancer Treatment)

We have 121 Masters Degrees (Cancer Treatment)

  • "cancer" AND "treatment" ×
  • clear all
Showing 1 to 15 of 121
Order by 
The Cancer MSc reflects the depth and breadth of research interests, from basic science to translational medicine, within the UCL Cancer Institute. Read more

The Cancer MSc reflects the depth and breadth of research interests, from basic science to translational medicine, within the UCL Cancer Institute. The programme, taught by research scientists and academic clinicians, provides students with an in-depth look at the biology behind the disease processes which lead to cancer.

About this degree

This programme offers a foundation in understanding cancer as a disease process and its associated therapies. Students learn about the approaches taken to predict, detect, monitor and treat cancer, alongside the cutting-edge research methods and techniques used to advance our understanding of this disease and design better treatment strategies.

Students undertake modules to the value of 180 credits.

The programme consists of two core modules (60 credits), four specialist modules (60 credits) and a research project (60 credits).

A Postgraduate Diploma (120 credits, full-time nine months) is offered.

A Postgraduate Certificate (60 credits, full-time 12 weeks) is offered.

Core modules

  • Basic Biology and Cancer Genetics
  • Cancer Therapeutics

Specialist modules

  • Behavioural Science and Cancer
  • Biomarkers in Cancer
  • Cancer Clinical Trials
  • Haematological Malignancies and Gene Therapy

Dissertation/report

All MSc students undertake a laboratory project, clinical trials project or systems biology/informatics project, which culminates in a 10,000–12,000 word dissertation and an oral research presentation.

Teaching and learning

Students develop their knowledge and understanding of cancer through lectures, self-study, database mining, wet-lab based practicals, clinical trial evaluations, laboratory training, assigned reading and self-learning. Each taught module is assessed by an unseen written examination and/or coursework. The research project is assessed by the dissertation (75%) and oral presentation (25%).

Further information on modules and degree structure is available on the department website: Cancer MSc

Careers

The knowledge and skills developed will be suitable for those in an industrial or healthcare setting, as well as those individuals contemplating a PhD or medical studies in cancer.

Employability

Skills include critical evaluation of scientific literature, experimental planning and design interpretation of data and results, presentation/public speaking skills, time management, working with a team, working independently and writing for various audiences.

Why study this degree at UCL?

UCL is one of Europe's largest and most productive centres of biomedical science, with an international reputation for leading basic, translational and clinical cancer research.

The UCL Cancer Institute brings together scientists from various disciplines to synergise multidisciplinary research into cancer, whose particular areas of expertise include: the biology of leukaemia, the infectious causes of cancer, the design of drugs that interact with DNA, antibody-directed therapies, the molecular pathology of cancer, signalling pathways in cancer, epigenetic changes in cancer, gene therapy, cancer stem cell biology, early phase clinical trials, and national and international clinical trials in solid tumours and blood cancers.

Research Excellence Framework (REF)

The Research Excellence Framework, or REF, is the system for assessing the quality of research in UK higher education institutions. The 2014 REF was carried out by the UK's higher education funding bodies, and the results used to allocate research funding from 2015/16.

The following REF score was awarded to the department: Cancer Institute

80% rated 4* (‘world-leading’) or 3* (‘internationally excellent’)

Learn more about the scope of UCL's research, and browse case studies, on our Research Impact website.



Read less
This programme aims to provide you with a clear understanding of the scientific basis underlying the principles and practice of treating cancer. Read more
This programme aims to provide you with a clear understanding of the scientific basis underlying the principles and practice of treating cancer.

This will be underpinned by a thorough knowledge of cancer biology and pathology and research methodologies.

This knowledge will provide an excellent grounding in the development, use and evaluation of cancer therapies, which will enhance career prospects in many areas of early phase clinical trials and clinical drug development in the cancer setting.

Compulsory Modules

• Ablative Therapies
• Cancer Biology
• Cancer Pharmacology
• Cancer Prevention & Screening
• Drug Development
• Molecular Diagnostic & Therapeutics
• Molecular Targeted Therapies and Immunotherapy for Blood Cancer
• Research Methods
• Site Specific Tumour Treatment

Elective Modules

• Genomic Approaches to Human Diseases
• Paediatric & Adolescent Oncology
• Pathology of Cancer

Core Module for MSc

• Dissertation.

Barts Cancer Institute is a Cancer Research UK Centre of Excellence and one of the leading cancer institutes in the country.
Based in the heart of London, our programmes are all taught by experts in the field.

Find out more about the BCI at http://www.bci.qmul.ac.uk/study-with-us

Read less
This programme aims to provide you with a clear understanding of molecular and cellular biology that is fundamental to cancer biology and cancer research. Read more
This programme aims to provide you with a clear understanding of molecular and cellular biology that is fundamental to cancer biology and cancer research.

You will learn how research in this area has advanced the treatment and diagnoses of cancer, and gain knowledge of how new therapies are developed, evaluated and implemented.

You will gain a thorough knowledge of research methodologies and laboratory techniques, which you will fully utilise in the laboratory research project stage. The valuable research experience you will gain from working with leading cancer experts, will give you a solid foundation upon which a future career in scientific research can be built.

Compulsory Modules

• Biological Therapies
• Cancer Biology
• Cancer Pharmacology
• Drug Development
• Genomic Approaches to Human Diseases
• Molecular Diagnostic & Therapeutics
• Pathology of Cancer
• Research Lab Skills
• Research Methods

Elective Modules

• Cancer Prevention & Screening
• Paediatric & Adolescent Oncology

Core Module for MSc

• Lab project


Barts Cancer Institute is a Cancer Research UK Centre of Excellence and one of the leading cancer institutes in the country.
Based in the heart of London, our programmes are all taught by experts in the field.

To find out more about BCI visit http://www.bci.qmul.ac.uk/study-with-us

Read less
Our MRes Experimental Cancer Medicine master's course will give nurses, doctors and clinical researchers the skills needed to work in early phase clinical studies. Read more

Our MRes Experimental Cancer Medicine master's course will give nurses, doctors and clinical researchers the skills needed to work in early phase clinical studies.

You will learn how to master experimental cancer through a combination of traditional teaching and hands-on learning, spending a year as a member of the Experimental Cancer Medicine Team at The Christie while also taking four structured taught units.

The taught units will see you learn the details of designing and delivering Phase 1 clinical studies, understanding the pre-clinical data required before a clinical programme can commence, and how to optimise early clinical studies to provide evidence for progressing a promising drug into Phase II/III clinical testing.

Alongside the taught elements, you will be allocated to one or more clinical trials that are being conducted by The Christie experimental cancer medicine team. You will have a named trainer and be exposed to tasks required in the setup, delivery, interpretation and audit of a clinical study.

Nursing and physician students will be expected to participate in patient care, including new and follow-on patient clinics, treatment and care-giving episodes with patients.

For clinical trials coordinators, no direct patient contact is envisaged and duties will involve clinical trial setup, protocol amendments, database setup, data entry, costing and billing for clinical research.

You will be able to choose two aspects of your direct clinical trial research experience to write up for your two research projects in a dissertation format. This will give you the skills and knowledge required to critically report medical, scientific and clinically related sciences for peer review.

Aims

The primary purpose of the MRes in Experimental Cancer Medicine is to provide you with the opportunity to work within a premier UK Phase 1 cancer clinical trials unit and, through a mix of taught and experiential learning, master the discipline of Experimental Cancer Medicine.

Special features

Extensive practical experience

You will spend most of your time gaining hands-on experience within The Christie's Experimental Cancer Medicine Team.

Additional course information

Meet the course team

Dr Natalie Cook is a Senior Clinical Lecturer in Experimental Cancer Medicine at the University and Honorary Consultant in Medical Oncology at The Christie. She completed a PhD at Cambridge, investigating translational therapeutics and biomarker assay design in pancreatic cancer.

Professor Hughes is Chair of Experimental Cancer Medicine at the University and Strategic Director of the Experimental Cancer Medicine team at The Christie. He is a member of the research strategy group for Manchester Cancer Research Centre. He serves on the Biomarker evaluation review panel for CRUK grant applications.

Professor Hughes was previously Global Vice-President for early clinical development at AstraZeneca, overseeing around 100 Phase 0/1/2 clinical studies. He was previously Global Vice-President for early phase clinical oncology, having been involved in over 200 early phase clinical studies.

Dr Matthew Krebs is a Clinical Senior Lecturer in Experimental Cancer Medicine at the University and Honorary Consultant in Medical Oncology at The Christie.

He has a PhD in circulating biomarkers and postdoctoral experience in single cell and ctDNA molecular profiling. He is Principal Investigator on a portfolio of phase 1 clinical trials and has research interests in clinical development of novel drugs for lung cancer and integration of biomarkers with experimental drug development.

Teaching and learning

Our course is structured around a 2:1 split between clinical-based research projects and taught elements respectively.

Taught course units will predominantly use lectures and workshops.

For the research projects, teaching and learning will take place through one-to-one mentoring from a member of the Experimental Cancer Medicine team.

The clinical and academic experience of contributors to this course will provide you with an exceptional teaching and learning experience.

Coursework and assessment

You will be assessed through oral presentations, single best answer exams, written reports and dissertation.

For each research project, you will write a dissertation of 10,000 to 15,000 words. Examples of suitable practical projects include the following.

Research proposal

  • Compilation of a research proposal to research council/charity
  • Writing a protocol and trial costings for sponsor
  • Research and write a successful expression of interest selected by grant funder for full development

Publication-based/dissertation by publication

  • Writing a clinical study report
  • Authoring a peer-review journal review/original article

Service development/professional report/ report based dissertation

  • Public health report/outbreak report/health needs assessment/health impact assessment
  • Proposal for service development/organisational change
  • Audit/evaluate service delivery/policy
  • Implement recommended change from audit report

Adapted systematic review (qualitative data)

  • Compiling the platform of scientific evidence for a new drug indication from literature
  • Review of alternative research methodologies from literature

Full systematic review that includes data collection (quantitative data)

  • Referral patterns for Phase 1 patients

Qualitative or quantitative empirical research

  • Design, conduct, analyse and report an experiment

Qualitative secondary data analysis/analysis of existing quantitative data

  • Compilation, mining and analysis of existing clinical data sets

Quantitative secondary data analysis/analysis of existing qualitative data/theoretical study/narrative review

  • Policy analysis or discourse analysis/content analysis
  • A critical review of policy using framework analysis

Facilities

Teaching will take place within The Christie NHS Foundation Trust , Withington.

Disability support

Practical support and advice for current students and applicants is available from the Disability Advisory and Support Service. Email: 

Career opportunities

This course is relevant to physician, nursing and clinical research students who are considering a career in Phase 1 clinical studies.

The course provides a theoretical and experiential learning experience and offers a foundation for roles within other experimental cancer medicine centres within the UK and EU, as well as careers in academia, the pharmaceutical industry, clinical trials management and medicine.

The MRes is ideal for high-calibre graduates and professionals wishing to undertake directly channelled research training in the clinical and medical oncology field.



Read less
This programme aims to provide you with a clear understanding of the scientific basis underlying the principles and practice of clinical oncology and the development, evaluation and implementation of new treatments. Read more
This programme aims to provide you with a clear understanding of the scientific basis underlying the principles and practice of clinical oncology and the development, evaluation and implementation of new treatments.

This will be underpinned by a thorough knowledge of cancer biology and pathology, drug development and research methodologies.

This knowledge will provide you with a good grounding in oncology within a clinical setting which will enhance prospects for those wanting to pursue a clinical academic career.

Compulsory Modules

• Ablative Therapies
• Cancer Biology
• Cancer Pharmacology
• Cancer Prevention & Screening
• Drug Development
• Genomic Approaches to Human Diseases
• Imaging
• Paediatric & Adolescent Oncology
• Pathology of Cancer
• Research Methods
• Site Specific Tumour Treatment

Elective Modules

• Biological Therapies
• Molecular Targeted Therapies and Immunotherapy for Blood Cancer

Core Module for MSc

• Dissertation

Barts Cancer Institute is a Cancer Research UK Centre of Excellence and one of the leading cancer institutes in the country.
Based in the heart of London, all our programmes are taught by experts in the field.

To find out more about BCI visit http://www.bci.qmul.ac.uk/study-with-us

Read less
Cell-to-cell signalling in development and disease. Do you have a clear and specific interest in cancer, stem cells or developmental biology? Our Master’s programme. Read more

Cell-to-cell signalling in development and disease

Do you have a clear and specific interest in cancer, stem cells or developmental biology? Our Master’s programme Cancer, Stem Cells and Developmental Biology combines research in three areas: oncology, molecular developmental biology and genetics. The focus is on molecular and cellular aspects of development and disease, utilising different model systems (mice, zebrafish, C. elegans, organoids and cell lines). The programme will guide you through the mysteries of embryonic growth, stem cells, signalling, gene regulation, evolution, and development as they relate to health and disease.

The right choice for you?

Given that fundamental developmental processes are so often impacted by disease, an understanding of these processes is vital to the better understanding of disease treatment and prevention. Adult physiology is regulated by developmental genes and mechanisms which, if deregulated, may result in pathological conditions. If you have a specific interest in cancer, stem cells or developmental biology, this Master’s programme is the right choice for you. Cancer, Stem Cells and Developmental Biology offers you international, high ranked research training and education that builds on novel methodology in genomics, proteomics, metabolomics and bioinformatics technology applied to biomedical and developmental systems and processes.

What you’ll learn

In the Cancer, Stem Cells and Developmental Biology programme you will learn to focus on understanding processes underlying cancer and developmental biology using techniques and applications of post-genomic research, including microarray analysis, next generation sequencing, proteomics, metabolomics and advanced microscopy techniques. You explore research questions concerning embryonic growth, stem cells, signaling pathways, gene regulation, evolution and development in relation to health and disease using various model systems. As a Master’s student you will take theory courses and seminars, as well as master classes led by renowned specialists in the field. The courses are interactive, and challenge you to further improve your writing and presenting skills.

Why study Cancer, Stem Cells and Developmental Biology at Utrecht University?

Compared to most other Master’s programmes in cancer and stem cell biology in the Netherlands, in Utrecht we offer:

  • Strong focus on fundamental molecular aspects of disease related questions, particularly questions related to cancer and the use of stem cells in regenerative medicine
  • A unique emphasis on Developmental Biology, a process with many connections to cancer
  • The opportunity to carry out two extensive research projects at renowned research groups
  • An intensive collaboration with national and international research institutes, allowing you to do your internship at prestigious partner institutions all around the world

Career in Cancer, Stem Cells and Developmental Biology

As a MSc graduate trained in both fundamental and disease-oriented aspects of biomedical genetics you are in great demand. You’ll be prepared for PhD study in one of the participating or associated groups. Alternatively, leaving after obtaining your MSc degree you will profit from a solid education in molecular genetics, in addition to your specialised knowledge of developmental biology. You’ll find your way to biotechnology, the pharmaceutical industry or education.



Read less
The area of cancer immunotherapy considers how to use conventional therapies including surgery, radiation and chemotherapy. Read more
The area of cancer immunotherapy considers how to use conventional therapies including surgery, radiation and chemotherapy. Whilst these treatment have served well and new drugs will continue to be designed, clinical trials over the last five years have shown that boosting the body’s immune system, whose main task is to deal with invading pathogens, can help our immune system to destroy tumour cells. Many of the new immunotherapies may be tested in combination with more conventional treatments or tested alone, but investigators and oncologists now believe immunotherapy, initially combined with pharmacological treatments, will soon provide curative therapies and certainly give many patients a new lease of life.

More about this course

Worldwide the incidence of cancer is increasing, and is expected to reach 22 million new cases per year by 2030. In addition to treatments such as radiotherapy and surgery, chemotherapy has a vital role to play in prolonging the lives of patients.

The aims of the Cancer Immunotherapy MSc are to:
-Provide an in-depth understanding of the molecular targets at which the different classes of anticancer drugs are aimed, and of how drug therapies are evolving
-Review the biology of cancer with respect to genetics, pathological considerations, and the molecular changes within cells which are associated with the progression of the disease
-Enhance intellectual and practical skills necessary for the collection, analysis, interpretation and understanding of scientific data
-Deliver a programme of advanced study to equip students for a future career in anti-cancer drug and immunotherapy development
-Cover new areas in immunotherapy (some of which may enhance existing pharmacological therapies including: History of immunotherapy and review of immune system; Monoclonal antibodies in cancer therapy and prevention; DNA vaccines against cancer; Adoptive T cell therapy; Dendritic cell vaccines; Antibodies that stimulate immunity; Adjuvant development for vaccines; Epigenetics and cancer: improving immunotherapy; Immuno-chemotherapy: integration of therapies; Exosomes and Microvesicles (EMVs) in cancer therapy and diagnosis; Dendritic cell vaccine development and Pox virus cancer vaccine vectors; Microbial causes of cancer and vaccination

Students will have access to highly qualified researchers and teachers in pharmacology and immunology, including those at the Cellular and Molecular Immunology Research Centre. Skills gained from research projects are therefore likely to be highly marketable in industry, academia and in the NHS. Students will be encouraged to join the British Society of Immunology and the International Society of Extracellular Vesicles.

Assessment is a combination of coursework, which includes tests and essays, the research project and its oral defence and examination.

Modular structure

The modules listed below are for the academic year 2016/17 and represent the course modules at this time. Modules and module details (including, but not limited to, location and time) are subject to change over time.

Year 1 modules include:
-Advanced Immunology (core, 20 credits)
-Cancer Immunotherapy (core, 20 credits)
-Cancer Pharmacology (core, 20 credits)
-Cancer: Diagnosis and Therapy (core, 20 credits)
-Molecular Oncology (core, 20 credits)
-Research Project (core, 60 credits)
-Scientific Frameworks for Research (core, 20 credits)

After the course

Students will have many opportunities to work in industry. There are established industries working hard to develop cancer immunotherapies including Bristol-Myers Squibbs, MERCK, AstraZeneca and Roche. There are also an innumerate number of start-up companies appearing including Omnis Pharma, UNUM Therapeutics and Alpine Immune Sciences.

Students will also have ample opportunity for future postgraduate study either within the School of Human Sciences and the Cellular and Molecular Immunology Centre at the MPhil/PhD level or beyond, even with some of our research partners within the UK, Europe and beyond.

Read less
This course will enhance your knowledge and understanding of cancer therapies and provide you with the skills to assess, analyse, critically appraise and evaluate current and emerging anti-cancer therapies and the drug discovery cascade, from target evaluation and engagement to clinical trials.. Read more
This course will enhance your knowledge and understanding of cancer therapies and provide you with the skills to assess, analyse, critically appraise and evaluate current and emerging anti-cancer therapies and the drug discovery cascade, from target evaluation and engagement to clinical trials.

The programme was developed in response to the increasing demand for a course which focuses on current and emerging cancer therapies. It is the only programme in the UK which combines a focus on cancer biology with the practical, ethical and economic implications of personalised cancer therapy, along with its biology and the discovery and development of drugs.

It has been constructed to produce world-class graduates with the skills to contribute to the global drive in advancing cancer treatment through research, teaching, industry and public sector employment.

What you'll study

You'll focus on anti-cancer treatment therapies, with a particular emphasis on personalised medicine, covering the therapeutic target and the biological mechanisms of current and emerging anti-cancer therapies. You'll also explore radiotherapy as a diagnostic and as a single or combinational treatment with drugs in anti-cancer therapy.

You'll be introduced to the discovery and development of new drugs and the challenges associated with this process. You'll be able to evaluate the drug discovery pipeline including medicinal chemistry, screening, secondary assays and other drug discovery and development technologies. Through a virtual drug discovery programme, you'll have the opportunity to develop anti-cancer agents and progress these through the drug discovery cascade, from target engagement to clinical trials.

The programme will equip you with a range of skills including scientific writing, critical analysis, problem-solving, teamworking, as well as advanced data set analysis and interpretation. You'll experience a wide range of scientific topics from molecular biology, to cell biology and genetics, medicinal chemistry to formulation and radiobiology to nuclear medicine. You'll have the opportunity to conduct independent research and working as part of a multidisciplinary team you'll gain an appreciation of the contributions other disciplines make to cancer drug discovery. 

Facilities

The Strathclyde Institute of Pharmacy and Biomedical Sciences is recognised as one of the foremost departments of its kind in the UK. It's a leading research centre in the search for new and improved medicines. You'll benefit from the advanced facilities of a new £36 million building. The Institute is ranked no 2 in the UK in the Complete University Guide 2018 and the University of Strathclyde has recently been one of the few UK institutes to be awarded the status of 'Emerging Centre of excellence for radiobiology research' in the UK.

Careers

Graduates will have a number of potential employment opportunities: large and small pharma companies, SMEs, within health services and providers, their home institutions and as academics in UK, EU or international Universities.

The course will enable careers in research, academia industry and the health sector and offers you a unique exposure to the entire drug discovery and development cascade while keeping patients' needs at the forefront of the learning process.

Read less
Clinicians, scientists and students engaged in cancer research at Newcastle share a common purpose. to improve treatment outcomes for patients with cancer. Read more
Clinicians, scientists and students engaged in cancer research at Newcastle share a common purpose: to improve treatment outcomes for patients with cancer. Work covers a broad spectrum - understanding the biological and molecular differences between normal and malignant cells and using this knowledge to develop new anti-cancer drugs.

Our staff and postgraduate students are based in the Northern Institute for Cancer Research (NICR) or the School of Chemistry. The NICR incorporates the Newcastle Cancer Centre, a unique collaboration between Cancer Research UK and the North of England Children's Cancer Research Fund.

We are a major training base for the next generation of cancer researchers. Our Institute covers many areas of cancer research, including:
-Solid tumours and leukaemias
-Childhood and adult cancers
-Drug discovery and early phase clinical trials

We offer approximately 15 MD, PhD and integrated MRes/PhD studentships each year, including the Newcastle Cancer Centre training programme. Projects in all research areas are available to fully-funded international students.

Members of our postgraduate community come from a variety of subject backgrounds including biological and biomedical sciences, chemistry, genetics, pharmacy, medicine, dentistry and veterinary medicine.

We hold regular postgraduate seminars which you will be required to attend and where you will deliver presentations. You will also attend and present your data annually at national cancer research meetings and at least one international meeting.

Placements

Our Institute has close working relationships with companies in the pharmaceutical and biotechnology sectors.

A number of our studentships are direct collaborations with industrial partners, with opportunities to spend placements with these partners.

Facilities

Our staff and postgraduate students are based in the Northern Institute for Cancer Research (NICR) or the School of Chemistry (medicinal chemistry students).

Our laboratories contain a full range of contemporary genomic, bioinformatic, proteomic, synthetic chemistry and pharmacology equipment, and clinical research facilities.

Read less
The MSc in Cancer Biology is for students who wish to gain an advanced education and training in the biological sciences, within the context of a disease that affects a large proportion of the global population. Read more
The MSc in Cancer Biology is for students who wish to gain an advanced education and training in the biological sciences, within the context of a disease that affects a large proportion of the global population.

The programme provides training in the modern practical, academic and research skills that are used in academia and industry. Through a combination of lectures, small-group seminars and practical classes, students will apply this training towards the development of new therapies.

The programme culminates with a research project that investigates the molecular and cellular basis of cancer biology or the development of new therapies under the supervision of active cancer research scientists.

Visit the website: https://www.kent.ac.uk/courses/postgraduate/226/cancer-biology

About the School of Biosciences

The School of Biosciences is among the best-funded schools of its kind in the UK, with current support from the BBSRC, NERC, MRC, Wellcome Trust, EU, and industry. It has 38 academic staff, 56 research staff (facility managers, research fellows, postdoctoral researchers and technicians), approximately 100 postgraduate students and 20 key support staff. The school's vibrant atmosphere has expanded to become a flourishing environment to study for postgraduate degrees in a notably friendly and supportive teaching and research environment.

Research in the School of Biosciences revolves around understanding systems and processes in the living cell. It has a strong molecular focus with leading-edge activities that are synergistic with one another and complementary to the teaching provision. Our expertise in disciplines such as biochemistry, microbiology and biomedical science allows us to exploit technology and develop groundbreaking ideas in the fields of genetics, molecular biology, protein science and biophysics. Fields of enquiry encompass a range of molecular processes from cell division, transcription and translation through to molecular motors, molecular diagnostics and the production of biotherapeutics and bioenergy.

In addition to research degrees, our key research strengths underpin a range of unique and career-focused taught Master’s programmes that address key issues and challenges within the biosciences and pharmaceutical industries and prepare graduates for future employment.

Course structure

Each one-hour lecture is supplemented by two hours of small-group seminars and workshops in which individual themes are explored in-depth. There are practical classes and mini-projects in which you design, produce and characterise a therapeutic protein with applications in therapy.

In additional to traditional scientific laboratory reports, experience will be gained in a range of scientific writing styles relevant to future employment, such as literature reviews, patent applications, regulatory documents, and patient information suitable for a non-scientific readership.

Modules

The following modules are indicative of those offered on this programme. This list is based on the current curriculum and may change year to year in response to new curriculum developments and innovation. Most programmes will require you to study a combination of compulsory and optional modules. You may also have the option to take modules from other programmes so that you may customise your programme and explore other subject areas that interest you.

BI830 - Science at Work (30 credits)
BI836 - Practical and Applied Research Skills for Advanced Biologists (30 credits)
BI837 - The Molecular and Cellular Basis of Cancer (15 credits)
BI838 - Genomic Stability and Cancer (15 credits)
BI840 - Cancer Therapeutics: From the Laboratory to the Clinic (15 credits)
BI857 - Cancer Research in Focus (15 credits)
BI845 - MSc Project (60 credits)

Assessment

The programme features a combination of examinations and practically focused continuous assessment, which gives you experience within a range of professional activities, eg, report writing, patent applications and public health information. The assessments have been designed to promote employability in a range of professional settings.

Programme aims

This programme aims to:

- provide an excellent quality of postgraduate-level education in the field of cancer, its biology and its treatment

- provide a research-led, inspiring learning environment

- provide a regional postgraduate progression route for the advanced study of a disease that affects a high proportion of the population

- promote engagement with biological research into cancer and inspire you to pursue a scientific career inside or outside of the laboratory

- develop subject specific and transferable skills to maximise employment prospects

- promote an understanding of the impact of scientific research on society and the role for scientists in a range of professions.

Research areas

Research in the School of Biosciences is focused primarily on essential biological processes at the molecular and cellular level, encompassing the disciplines of biochemistry, genetics, biotechnology and biomedical research.

The School’s research has three main themes:

- Protein Science – encompasses researchers involved in industrial biotechnology and synthetic biology, and protein form and function

- Molecular Microbiology – encompasses researchers interested in yeast molecular biology (incorporating the Kent Fungal Group) and microbial pathogenesis

- Biomolecular Medicine – encompasses researchers involved in cell biology, cancer targets and therapies and cytogenomics and bioinformatics.

Each area is led by a senior professor and underpinned by excellent research facilities. The School-led development of the Industrial Biotechnology Centre (IBC), with staff from the other four other schools in the Faculty of Sciences, facilitates and encourages interdisciplinary projects. The School has a strong commitment to translational research, impact and industrial application with a substantial portfolio of enterprise activity and expertise.

Careers

A postgraduate degree in the School of Biosciences is designed to equip our graduates with transferable skills that are highly valued in the workplace. Our research-led ethos ensures that students explore the frontiers of scientific knowledge, and the intensive practical components provide rigorous training in cutting edge technical skills that are used in the modern biosciences while working in areas of world-leading expertise within the School.

Destinations for our graduates include the leading pharmaceutical and biotechnological companies within the UK and leading research institutes both at home and abroad.

Find out how to apply here - https://www.kent.ac.uk/courses/postgraduate/apply-online/226

Read less
Therapeutic radiographers are at the forefront of cancer care, having a vital role in the delivery of Radiotherapy services. They treat cancer patients with x-rays using highly sophisticated equipment. Read more
Therapeutic radiographers are at the forefront of cancer care, having a vital role in the delivery of Radiotherapy services. They treat cancer patients with x-rays using highly sophisticated equipment. They are also responsible for ensuring that treatment planning and delivery is achieved with absolute precision.

In the treatment of cancer, accuracy is paramount and a variety of highly specialised equipment is available within Radiotherapy Departments to achieve this. Computerised Tomography (CT) simulators employ the latest technology to localise tumours.

Technological advances

Technological advances in linear accelerator design ensure that treatment conforms to patients needs with pinpoint accuracy. Treatment units housing radioactive sources also play a useful role in patient management, as do 3D planning systems.

London South Bank University has invested heavily to ensure that students have access to the best learning tools and staff. There are two dedicated fully equipped skill labs that enable Dosimetry (Radiotherapy treatment planning) and a state of the art virtual environment of a radiotherapy treatment room (VERT).

Communication and care

Alongside the technology, the importance of high standards of communication and care of cancer patients cannot be overestimated. Cancer patients are treated by a multidisciplinary team in which the therapeutic radiographer plays a major role in reducing the sense of vulnerability and promoting patients autonomy.

As a graduate, you'll be eligible to apply for registration with the Health and Care Professions Council (HCPC) as a Radiographer .

PgDip programme

The PgDip programme is an accelerated programme over two years, for graduate students who already have a Level 6 qualification. Building on graduate skills you'll develop an enquiring, reflective, critical and innovative approach to Therapeutic Radiography within the context of the rapid changes occurring in the health service.

Top-up to MSc

By adding the research element of a dissertation (an extended and independent piece of written research), you'll be able to graduate with a Masters-level qualification.

Modules

On this programme we'll develop you as confident and competent practitioner who practices autonomously, compassionately, skilfully and safely. The programme comprises of five compulsory modules instilling a range of academic knowledge from health sciences to profession specific radiotherapy and oncology practice. And, add a dissertation for the award of a Masters.

Year 1

Radiation science and technology
Applied biological sciences
Radiotherapy theory and practice 1

Year 2

Patient care and resource management in radiotherapy
Radiotherapy theory and practice 2
Dissertation (MSc only)

Teaching and learning

Academic theoretical knowledge is gained through taught session led by lecturers and experts in the field, supported by blended learning and self-study activities.

Practical skills are normally developed through practical skills based sessions using VERT and dosimetry software, problem-based approaches and clinical placement.

Types of learning activities include:

• Lectures
• Seminars
• Enquiry-based learning
• Tutorials
• Formative assessments
• E discussions
• Observation and demonstration of practices within clinical placements.

Placements

Clinical placements are an essential element of the course. You will spend 50% of your time involved in academic study and 50% in clinical practice within a broad variety of healthcare settings. A clinical practice placement allows you to put theory into practice by working with a range of health professionals in clinical situations to develop the skills, knowledge and experience required to become a competent radiographer. Although sometimes initially challenging, practice learning is one of the most interesting and exciting aspects of learning to be a radiographer.

Clinical settings

At LSBU you will experience a variety of clinical settings such as NHS Trusts and the independent sector.

Placements for Therapeutic Radiography include:

• Brighton and Sussex University Hospital: Sussex Cancer Centre
• Maidstone and Tunbridge Wells NHS Trust: Kent Oncology Centre
• Guy's and St Thomas' NHS Foundation Trust
• Royal Surrey Hospital
• Queens Hospital, Romford.

Structure of placements

Placements are spread over two years.

The first clinical placement; approximately seven weeks after the start of the course, gives a real taster of the role of the radiotherapy radiographer in the radiotherapy treatment process. It gives you an opportunity to confirm correct choice of career early within the course. Thereafter clinical placements follow the same pattern throughout the course.

Support from a mentor

An identified Link Lecturer and Personal Tutor from the University will be the person you can contact during working day hours whilst on placement with any concerns or questions you are unable to solve otherwise. As there is a close relationship between LSBU and the clinical placement; the Link Lecturer will pay regular scheduled visits to the different sites to meet up with students.

Professional links

The programme is validated by the Health and Care Professions Council (HCPC) and accredited by the Society and College of Radiographers.

Radiotherapy as a career

On successful completion of the course you'll be eligible to register with the Health and Care Professions Council (HCPC) as a therapeutic radiographer.

From helping plan and administering treatment, to explaining it to patients and assessing their responses, therapeutic radiographers are involved in every stage of the treatment process.

Therapeutic radiographers work closely with professionals from other disciplines, are involved in the care and support of the cancer patient and their families through all parts of the patient pathway from the initial referral through to treatment review and follow-up stages. They are predominantly responsible for treatment for the accurate localisation, planning and delivery of ionising radiation.

Therapeutic radiographers need excellent interpersonal skills and emotional resilience as they deal with patients and their families at very difficult and emotional times. Making patients feel comfortable and guiding them through the process can be as important as the technical skills required for this role.

Career progression

Through the acquisition of a wide range of transferable skills such as psychosocial, organisational, management, technical and scientific skills, individuals are well prepared to work in any situation that best suits their individual expertise and interest.Working as a consultant practitioner is one common career path as well as management, research, clinical work and teaching.

After qualification, clinically experienced therapeutic radiographers may gain additional specialist skills and expertise through the postgraduate, post-registration and continuing professional development frameworks.

LSBU Employability Services

LSBU is committed to supporting you develop your employability and succeed in getting a job after you have graduated. Your qualification will certainly help, but in a competitive market you also need to work on your employability, and on your career search. Our Employability Service will support you in developing your skills, finding a job, interview techniques, work experience or an internship, and will help you assess what you need to do to get the job you want at the end of your course. LSBU offers a comprehensive Employability Service, with a range of initiatives to complement your studies, including:

• Direct engagement from employers who come in to interview and talk to students
• Job Shop and on-campus recruitment agencies to help your job search
• Mentoring and work shadowing schemes.

Read less
Our MSc in Cancer Biology and Radiotherapy Physics is ideal if you wish to pursue a career in cancer research and/or cancer therapy involving ionising radiation. Read more

Our MSc in Cancer Biology and Radiotherapy Physics is ideal if you wish to pursue a career in cancer research and/or cancer therapy involving ionising radiation.

With around 40% of all cancer cure cases involving radiotherapy and the UK soon to have a proton therapy service, the need for multidisciplinary scientists in this field has never been greater.

We aim to develop multidisciplinary scientists to create the necessary skill base that will drive radiotherapy forward in the UK.

This course will enable you to train as a multidisciplinary scientist in this area by covering a variety of subjects in content that is delivered by staff with a range of expertise, including physicists, biologists, engineers, clinicians and oncologists.

Our collaboration with The Christie will allow you to undertake unique research projects in its radiotherapy facilities that cannot be carried out anywhere else in the UK or most of Europe.

Aims

This course aims to help you develop:

  • a sound scientific knowledge of cancer biology and radiotherapy physics;
  • the confidence to apply the scientific principles of radiotherapy to practical situations;
  • the multidisciplinary skills required for world-leading cancer research and treatment delivery;
  • a knowledge of cancer biology that can form a basis for research into existing and future treatment modalities.

Teaching and learning

You will be taught by academics from the University and clinical scientists at The Christie, meaning both fundamental science and its clinical application will be covered equally.

Units are delivered in one-week blocks with a mix of face-to-face content delivery and hands-on practical sessions.

There will be a number of assessed and non-assessed activities to develop your key skills and expand your knowledge base.

There is an also online pre-course element, which will be the beginning of your multidisciplinary scientific journey.

After the taught units, there is an supervised research project that will put into practice the key skills and knowledge acquired in the taught component.

Coursework and assessment

The taught units will be assessed through multiple choice exams and practical assessments.

The research project will be assessed through the submission of a short report and oral presentation.

Course unit details

The taught component, which includes the five core and three optional units, will amount to 120 credits of the 180 credits required for an MSc qualification.

The remaining 60 credits will be obtained through a supervised research project.

Core units

  • The Physics of Radiotherapy
  • The Biology of Cancer
  • Clinical Radiotherapy
  • Radiobiology

Optional units

  • Advanced Radiotherapy
  • Imaging for Radiotherapy
  • Radiotherapy Dosimetry
  • Treatment Planning
  • Biomarkers
  • Computational Methods
  • Accelerators for Medicine

Course collaborators

Much of the course content is delivered through a collaboration with  The Christie .

Facilities

Our collaboration with  The Christie  means you will have access to an MRI image guided radiotherapy linear accelerator and a proton therapy centre incorporating a dedicated research room for your research project.

You will also be able to access a range of library and IT  facilities  throughout the University.

Disability support

Practical support and advice for current students and applicants is available from the  Disability Advisory and Support Service .

CPD opportunities

Individual taught units from this MSc can be offered to industry and healthcare professionals as part of a career and professional development programme. Please contact us for further information.

Career opportunities

This course will help you gain the knowledge and skills to become a leading healthcare scientist in the public or private sector.

It may also be of interest if you are a healthcare worker in the field of radiotherapy who wishes to advance your career.

The master's qualification gained could act as a stepping stone to further academic qualifications or careers involving medical science research.



Read less
The Cancer Sciences MRes is a one year, full time programme introduced to offer postgraduate training to suitably qualified science students who are interested in research careers in cancer. Read more
The Cancer Sciences MRes is a one year, full time programme introduced to offer postgraduate training to suitably qualified science students who are interested in research careers in cancer. It is a stand-alone programme that would be of particular interest to students who wish to apply for further training at PhD level.

Designed to offer life and biomedical science graduates the opportunity to gain research training through practical experience in a leading cancer research centre.

The programme consists of three introductory taught modules and an extensive project within a research group in the School of Cancer Sciences. The lecture modules will be taught by leading cancer experts and will cover such topics as the cellular and molecular basis of cancer, the pathology of selected cancers and how translational research is applied to diagnosis and treatment of cancers. The projects will generally be laboratory-based and will provide skills in designing and implementing research strategies to answer fundamental questions relating to cancer causes, diagnosis and/or treatment.

About the College of Medical and Dental Sciences

The College of Medical and Dental Sciences is a major international centre for research and education, make huge strides in finding solutions to major health problems including ageing, cancer, cardiovascular, dental, endocrine, inflammatory diseases, infection (including antibiotic resistance), rare diseases and trauma.
We tackle global healthcare problems through excellence in basic and clinical science, and improve human health by delivering tangible real-life benefits in the fight against acute and chronic disease.
Situated in the largest healthcare region in the country, with access to one of the largest and most diverse populations in Europe, we are positioned to address major global issues and diseases affecting today’s society through our eight specialist research institutes.
With over 1,000 academic staff and around £60 million of new research funding per year, the College of Medical and Dental Sciences is dedicated to performing world-leading research.
We care about our research and teaching and are committed to developing outstanding scientists and healthcare professionals of the future. We offer our postgraduate community a unique learning experience taught by academics who lead the way in research in their field.

Funding and Scholarships

There are many ways to finance your postgraduate study at the University of Birmingham. To see what funding and scholarships are available, please visit: http://www.birmingham.ac.uk/postgraduate/funding

Open Days

Explore postgraduate study at Birmingham at our on-campus open days.
Register to attend at: http://www.birmingham.ac.uk/postgraduate/visit

Virtual Open Days

If you can’t make it to one of our on-campus open days, our virtual open days run regularly throughout the year. For more information, please visit: http://www.pg.bham.ac.uk

Read less
This exciting new course is designed to equip future scientists with the knowledge to make a difference in the understanding and treatment of cancer. Read more
This exciting new course is designed to equip future scientists with the knowledge to make a difference in the understanding and treatment of cancer. The course will take the mechanistic understanding of cancer biology and apply it to the analysis of risk, prevention, diagnosis, prognosis and therapy. Building on a foundation of the understanding of basic cancer cell biology, translational coverage will consider design of treatment modalities, mechanisms of action of anti-cancer drugs, therapy resistance and biomarker discovery. The course will allow the students to gain expertise and knowledge in therapy, cancer chemoprevention, anti-cancer target discovery, clinical trials, imaging, cancer risk and epidemiology and biostatistics. A key component of the course is a five/six-month research project, which will give students an opportunity to study one of these areas in depth.

Read less
The use of chemotherapeutic agents to target and kill cancer cells is a central strategy in the treatment of cancers. This course describes the nature of the disease at the systems, cellular and molecular levels, and focuses on the drugs which are used to treat different cancers and on how they work. Read more
The use of chemotherapeutic agents to target and kill cancer cells is a central strategy in the treatment of cancers. This course describes the nature of the disease at the systems, cellular and molecular levels, and focuses on the drugs which are used to treat different cancers and on how they work.

More about this course

Worldwide the incidence of cancer is increasing, and is expected to reach 22 million new cases per year by 2030. In addition to treatments such as radiotherapy and surgery, chemotherapy has a vital role to play in prolonging the lives of patients.

The aims of this course are to:
-Provide you with an in-depth understanding of the molecular targets at which the different classes of anticancer drugs are aimed, and of how drug therapies are evolving;
-Review the biology of cancer with respect to genetics, pathological considerations, and the molecular changes within cells which are associated with the progression of the disease;
-Enhance intellectual and practical skills necessary for the collection, analysis, interpretation and understanding of scientific data;
deliver a programme of advanced study to equip you for a future career in anti-cancer drug development.

Assessment is a combination of coursework, which includes tests and essays, the research project and its oral defence and examination.

Modular structure

The modules listed below are for the academic year 2016/17 and represent the course modules at this time. Modules and module details (including, but not limited to, location and time) are subject to change over time.

Year 1 modules include:
-Cancer Pharmacology (core, 20 credits)
-Cancer: Diagnosis and Therapy (core, 20 credits)
-Medical Genetics (core, 20 credits)
-Molecular Oncology (core, 20 credits)
-Research Project (core, 60 credits)
-Scientific Frameworks for Research (core, 20 credits)
-Advanced Drug Formulation Technologies (option, 20 credits)
-Bioinformatics and Molecular Modelling (option, 20 credits)
-Drug Discovery Technology (option, 20 credits)

After the course

This course is primarily designed for those wishing to pursue a career in anti-cancer drug development, whether in academia or within the pharmaceutical industry. The programme provides an excellent basis for further research or study.

Moving to one campus

Between 2016 and 2020 we're investing £125 million in the London Metropolitan University campus, moving all of our activity to our current Holloway campus in Islington, north London. This will mean the teaching location of some courses will change over time.

Whether you will be affected will depend on the duration of your course, when you start and your mode of study. The earliest moves affecting new students will be in September 2017. This may mean you begin your course at one location, but over the duration of the course you are relocated to one of our other campuses. Our intention is that no full-time student will change campus more than once during a course of typical duration.

All students will benefit from our move to one campus, which will allow us to develop state-of-the-art facilities, flexible teaching areas and stunning social spaces.

Read less

Show 10 15 30 per page



Cookie Policy    X